Calling Dr. Bauer – September-2011

Many readers have asked Dr. Bauer about the need for antibiotics routinely when breathing symptoms become worse. Most all practitioners would support the notion that antibiotics are being vastly over-prescribed. There are many reasons for this. Patient expectations are a major factor. Advertizing by the big drug companies may also play a role. The fact…

Respiratory News-July-2011

    Respiratory News Annually changing flu vaccines may be a thing of the past when a single, near-universal flu vaccine becomes available! Scientists describe an antibody that, in animal tests, can prevent or cure infections from a broad variety of influenza viruses, including seasonal and potentially pandemic strains. The findings were published in the…

Medication News-July-2011

    Medication News The Food and Drug Administration (FDA) gave approval to a 75 mcg dosage of the inhaled drug, Indacaterol – a once-a-day, long-acting bronchodilator for treating COPD. Indacaterol is already sold in Europe under the brand name Onbrez Breezhaler at 150 mcg. It is scheduled to be available from Novartis in the…

Traveling News-July-2011

    Traveling News .Conference Highlights Concerns A recent conference on long term oxygen therapy brought health professionals together  to discuss the problems facing oxygen users today. One of the most common com- plaints the suppliers had was they feared their clients were trying to conserve their supply in tanks or battery time of portable…

Fibrosis File-July-2011

    Fibrosis File New Discovery May Lead to Treatments in PF Researchers at Duke University Medical Center discovered an invasive cell that leads to pul- monary fibrosis may be stopped by cutting off its supply of sugar. The results were published in a recent issue of Journal of Experimental Medicine. The Duke researchers identified…